Lastly, in view of our findings on the tumour suppressor role of CaSR in CML (Fig. 3b, d), we tested the effect of the CaSR agonist and calcimimetic cinacalcet40 on CML development (Supplementary Fig. 21a). This evidence concerns the gene CASR and neoplasm.